Evidence map›Paper›PMID 33907317›Full record

ArticleEuropean journal of human genetics : EJHG2021

Speech and language deficits are central to SETBP1 haploinsufficiency disorder.

Angela Morgan, Ruth Braden, Maggie M K Wong, Estelle Colin, David Amor, Frederique Liégeois, Siddharth Srivastava, Adam Vogel, Varoona Bizaoui, Kara Ranguin and 2 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Behavioral and Prefrontal Circuit Deficits in a Newly DevelopedBiological psychiatry global open science · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencing.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  10. Investigating Sequence Variations inClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  11. Article
  12. Article
  13. Speech and language classification in the human phenotype ontology.European journal of human genetics : EJHG · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The impact of SETBP1 mutations in neurological diseases and cancer.Genes to cells : devoted to molecular & cellular mechanisms · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Angela Morgan *Speech & Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. angela.morgan@mcri.edu.au.ORCID http://orcid.org/0000-0003-1147-7405
Ruth Braden *Speech & Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Maggie M K WongLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-9438-0141
Estelle ColinService de Génétique Médicale, Centre Hospitalier Universitaire d'Angers, Angers, France.ORCID http://orcid.org/0000-0001-7913-3938
David AmorSpeech & Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Frederique LiégeoisUCL Great Ormond Street Institute of Child Health, London, UK.
Siddharth SrivastavaBoston Children's, Harvard Medical Centre, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7008-1879
Adam VogelCentre for Neuroscience of Speech, Department of Audiology and Speech Pathology, University of Melbourne, Melbourne, Victoria, Australia.
Varoona BizaouiService de Génétique, Centre Hospitalier Universitaire Caen Normandie, Caen, France.
Kara RanguinService de Génétique, Centre Hospitalier Universitaire Caen Normandie, Caen, France.ORCID http://orcid.org/0000-0002-9732-8090
Simon E FisherLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-3132-1996
Bregje W van BonRadboud University Medical centre, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expressive communication impairment is associated with haploinsufficiency of SETBP1, as reported in small case series. Heterozygous pathogenic loss-of-function (LoF) variants in SETBP1 have also been identified in independent cohorts ascertained for childhood apraxia of speech (CAS), warranting further investigation of the roles of this gene in speech development. Thirty-one participants (12 males, aged 0; 8-23; 2 years, 28 with pathogenic SETBP1 LoF variants, 3 with 18q12.3 deletions) were assessed for speech, language and literacy abilities. Broader development was examined with standardised motor, social and daily life skills assessments. Gross and fine motor deficits (94%) and intellectual impairments (68%) were common. Protracted and aberrant speech development was consistently seen, regardless of motor or intellectual ability. We expand the linguistic phenotype associated with SETBP1 LoF syndrome (SETBP1 haploinsufficiency disorder), revealing a striking speech presentation that implicates both motor (CAS, dysarthria) and language (phonological errors) systems, with CAS (80%) being the most common diagnosis. In contrast to past reports, the understanding of language was rarely better preserved than language expression (29%). Language was typically low, to moderately impaired, with commensurate expression and comprehension ability. Children were sociable with a strong desire to communicate. Minimally verbal children (32%) augmented speech with sign language, gestures or digital devices. Overall, relative to general development, spoken language and literacy were poorer than social, daily living, motor and adaptive behaviour skills. Our findings show that poor communication is a central feature of SETBP1 haploinsufficiency disorder, confirming this gene as a strong candidate for speech and language disorders.

Indexed as

Language DevelopmentAdolescentCarrier ProteinsChildFemaleHaploinsufficiencyHumansMaleNuclear ProteinsPhenotypeSpeech DisordersYoung AdultCarrier ProteinsNuclear ProteinsSETBP1 protein, human

Identifiers

PMID33907317
PMCPMC8384874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.